APA (7th ed.) Citation

Cheung, D., Fong, A., Ding, H. T., Cabanski, C. R., Wang, J., Chen, Y., . . . Pan, L. (2021). A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects. Pulmonary pharmacology & therapeutics, 69, 102051. https://doi.org/10.1016/j.pupt.2021.102051

Chicago Style (17th ed.) Citation

Cheung, Dorothy, Alice Fong, Han Ting Ding, Christopher R. Cabanski, Jianshuang Wang, Yuan Chen, Jim Bush, Jeffrey M. Harris, and Lin Pan. "A Phase 1, Randomized Study to Evaluate Safety, Tolerability, and Pharmacokinetics of GDC-3280, a Potential Novel Anti-fibrotic Small Molecule, in Healthy Subjects." Pulmonary Pharmacology & Therapeutics 69 (2021): 102051. https://doi.org/10.1016/j.pupt.2021.102051.

MLA (9th ed.) Citation

Cheung, Dorothy, et al. "A Phase 1, Randomized Study to Evaluate Safety, Tolerability, and Pharmacokinetics of GDC-3280, a Potential Novel Anti-fibrotic Small Molecule, in Healthy Subjects." Pulmonary Pharmacology & Therapeutics, vol. 69, 2021, p. 102051, https://doi.org/10.1016/j.pupt.2021.102051.